, Tracking Stock Market Picks
Enter Symbol:

down 99.74 %

ASPENBIO PHARMA INC (APPY) rated Buy with price target $15 by Lazard Capital

Posted on: Tuesday,  Jun 24, 2008  8:25 AM ET by Lazard Capital

Lazard Capital rated Buy ASPENBIO PHARMA INC (NASDAQ: APPY) on 06/24/2008, when the stock price was $157.20. Since
then, ASPENBIO PHARMA INC has lost 99.75% as of 09/10/2015's recent price of $0.40.
If you would have followed this Lazard Capital's recommendation on APPY, you would have lost 99.74% of your investment in 2634 days.

AspenBio Pharma, Inc. (AspenBio) is a biotechnology company engaged in the discovery, development, manufacture, and licensing or marketing of products. The Company is primarily focused on advancing towards commercialization its blood-based human diagnostic test, AppyScore to aid in the diagnosis of human appendicitis and several reproduction drugs for use in high value animals. AppyScore is a blood-based test to the aid in diagnosis of appendicitis. AppyScore measures the abundance of MRP 8/14, an inflammation biomarker, which AspenBio has identified to be elevated in acute appendicitis and demonstrates a correlation to the severity of the disease. In December 2008, the Company completed an 800 patient pivotal clinical trial for AppyScore. Products in its pipeline consist of product candidates in various stages of clinical and pre-clinical development.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/24/2008 8:25 AM Buy
157.20 450.00
as of 12/24/2008
1 Week down  -3.52 %
1 Month down  -1.20 %
3 Months up  6.49 %
1 YTD down  -73.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy